Are limits on the spread of new technologies inevitable? If so, how can they best be achieved?

Costly new technologies continue to spread rapidly--often, before their usefulness in routine patient care is established or despite indications that an appropriate level of diffusion has already been reached. Hospitals and other providers can contain health care costs by exercising restraint in their decisions about new technologies and may face renewed technology-acquisition controls if they fail to do so.